Open-label Study of Bevacizumab (AVASTIN®) in Combination With Platinum-containing Chemotherapy as First-line Treatment of Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer

by lowes1 on October 16, 2013

Conditions:   Non-small Cell Lung Cancer;   Unresectable
Intervention:  
Sponsors:   University of Athens;   University of Athens
Recruiting – verified October 2013

View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days

Leave a Comment

Previous post:

Next post: